Business Context and Reporting Period
Company: Kewaunee Scientific Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended July 31, 2004
Business Overview: The Company manufactures laboratory products and technical products for industrial research and high-tech markets.
Key Financial Metrics
| Metric | Q1 2005 (Ended July 31, 2004) | Q1 2004 (Ended July 31, 2003) |
|---|---|---|
| Net Sales | $20,288,000 | $24,213,000 |
| Gross Profit | $3,376,000 | $3,603,000 |
| Gross Margin | 16.6% | 14.9% |
| Operating Earnings | $330,000 | $602,000 |
| Net Earnings | $193,000 | $461,000 |
| Diluted EPS | $0.08 | $0.19 |
| Cash and Equivalents | $1,125,000 | $400,000 |
| Short-term Borrowings | $7,987,000 | $6,996,000 |
| Working Capital | $12,893,000 | $12,617,000 (Apr 30, 2004) |
| Order Backlog | $39,600,000 | $50,700,000 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 16.2% to $20.3 million, driven by slowed demand for laboratory products in industrial research and softer demand for technical products in the high-tech marketplace.
- Margin Improvement: Gross profit margin improved to 16.6% from 14.9% in the prior year. The prior year was negatively impacted by manufacturing problems in the metal furniture operation and unfavorable sales mix.
- Profitability Drop: Operating earnings fell to $330,000 from $602,000. Net earnings declined to $193,000 from $461,000.
- One-Time Items: The prior year's results included a $295,000 gain (pre-tax) from the resolution of a disputed claim for laboratory furniture, which is not present in the current period.
- Debt Levels: Short-term borrowings increased by approximately $1 million to $7.99 million, resulting in higher interest expense ($86,000 vs. $78,000).
Outlook, Risks, and Management Commentary
- Liquidity: Management believes funds from operations and short-term borrowings are sufficient to support ongoing business and capital expenditures through the current fiscal year. Available credit under the revolving line is $1.013 million.
- Cash Flow: Operating activities used $438,000 in cash, primarily due to a significant decrease in accounts payable and other current liabilities. This contrasts with the prior year, where operations used $5.4 million to fund increased receivables from higher sales volume.
- Capital Expenditures: Investing activities used $153,000 for production equipment, a significant reduction from $1.066 million in the prior year.
- Risks: Forward-looking statements are subject to economic, competitive, governmental, and technological factors. The Company utilizes interest rate swap agreements to manage interest rate risk.
Investor Verification Checklist
- Verify the sustainability of the improved gross margin (16.6%) given the decline in sales volume.
- Monitor the order backlog trend, which has decreased from $50.7 million (July 2003) to $39.6 million (July 2004).
- Assess the impact of increased short-term borrowings on future interest expenses and liquidity.
- Confirm the absence of the one-time $295,000 gain in future quarters to normalize earnings comparisons.
- Review the utilization of the revolving credit facility, as $7.99 million is currently outstanding with only $1.013 million remaining available.